[Prophylactic treatment of preeclampsia]

Gynakol Geburtshilfliche Rundsch. 2007;47(4):205-8. doi: 10.1159/000107260.
[Article in German]

Abstract

The pathophysiology of preeclampsia is still unknown. Low-dose aspirin showed a reduction of the preeclampsia rate in a high-risk situation.There is a lack of prospective randomized studies to prove the benefit of heparin treatment in patients with hereditary thrombophilia. Different prophylactic therapies did not show any benefit in the prevention of preeclampsia in clinical studies.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anticoagulants / administration & dosage*
  • Aspirin / administration & dosage*
  • Clinical Trials as Topic / trends
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Germany
  • Heparin / administration & dosage*
  • Humans
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians' / trends
  • Pre-Eclampsia / drug therapy*
  • Pre-Eclampsia / prevention & control*
  • Pregnancy

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin
  • Aspirin